← US Feed

Grace Therapeutics Announces $10 Million Private Placement

Source Summary

Expected gross proceeds anticipated to extend the Company’s cash runway to the end of calendar 2028 Expected gross proceeds anticipated to extend the Company’s cash runway to the end of calendar 2028

Advertisement
Read Original Article